Holen Sie sich die Stockscreener-App
3.18
0.63%
-0.02
Handel nachbörslich:
3.15
-0.03
-0.94%
Schlusskurs vom Vortag:
$3.20
Offen:
$3.17
24-Stunden-Volumen:
469.83K
Relative Volume:
0.30
Marktkapitalisierung:
$226.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-192.96M
KGV:
-0.9636
EPS:
-3.3
Netto-Cashflow:
$-167.04M
1W Leistung:
+0.47%
1M Leistung:
+32.50%
6M Leistung:
+41.33%
1J Leistung:
+9.66%
1-Tages-Spanne:
$3.13
$3.21
1-Wochen-Bereich:
$2.881
$3.2999
52-Wochen-Spanne:
$0.783
$3.39
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Firmenname
Ventyx Biosciences Inc
Sektor
Branche
Telefon
(858) 945-2393
Adresse
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Vergleichen Sie VTYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
3.18 | 227.72M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-12 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2023-11-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-03-21 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Buy |
| 2022-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-07 | Eingeleitet | Stifel | Buy |
| 2022-09-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-09 | Eingeleitet | Credit Suisse | Outperform |
| 2022-03-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-15 | Eingeleitet | Jefferies | Buy |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Ventyx Biosciences Inc Aktie (VTYX) Neueste Nachrichten
Should I hold or sell Ventyx Biosciences Inc. stock in 2025Exceptional profit velocity - jammulinksnews.com
What are the latest earnings results for Ventyx Biosciences Inc.High-impact investment strategies - jammulinksnews.com
Ventyx Biosciences Inc. Stock Support and Resistance Levels You Should KnowSolid Return Trade Selections - beatles.ru
How volatile is Ventyx Biosciences Inc. stock compared to the marketCapitalize on fast-growing investment opportunities - jammulinksnews.com
How Resilient Is Ventyx Biosciences Inc. Stock During Economic DownturnsHigh Win Rate Stock Ideas - Newser
What is the risk reward ratio of investing in Ventyx Biosciences Inc. stockDiscover stock picks with superior returns - jammulinksnews.com
Why Ventyx Biosciences Inc. stock attracts strong analyst attentionGrowth Stock Monitor - Newser
What analysts say about Ventyx Biosciences Inc. stockExceptional profit velocity - PrintWeekIndia
Ventyx Biosciences Inc. Stock Analysis and ForecastRapid market gains - PrintWeekIndia
Is Ventyx Biosciences Inc. a good long term investmentPowerful market insights - PrintWeekIndia
How Ventyx Biosciences Inc. stock performs during market volatilityPredictable Return Stock Picks - Newser
What drives Ventyx Biosciences Inc. stock priceTremendous growth opportunities - jammulinksnews.com
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth? - Yahoo Finance
What makes Ventyx Biosciences Inc. stock price move sharplyFree Insider Trading Tips - Newser
Wealth Enhancement Advisory Services LLC Invests $28,000 in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World
Ventyx Biosciences (VTYX) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Analyzing the Impact of Earnings Reports on Ventyx Biosciences Inc Inc. (VTYX) Price Performance - investchronicle.com
Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)April 30, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Ventyx Biosciences, Inc. (VTYX) Shareholders - ACCESS Newswire
Ventyx Biosciences, Inc.(NasdaqGS: VTYX) dropped from Russell 3000E Index - MarketScreener
Ventyx Biosciences, Inc.(NasdaqGS: VTYX) dropped from Russell 3000 Value Index - MarketScreener
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Shares Sold by Rhumbline Advisers - Defense World
Canaccord maintains buy rating on Ventyx stock after positive trial results - Investing.com
Ventyx stock steady as Parkinson’s drug shows biomarker reductions By Investing.com - Investing.com India
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):